UPClytics
Alle Fälle anzeigen

UPC APP 3514/2024

·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Verfahrensdetails
Status
Verfahrensart
Vorbescheid
Kategorie
Vorab-Einrede
Parteien
Kläger
Vertreter: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Robert Knaps (Kather Augenstein)
Beklagte
Vertreter: Charlotte Garnitsch (Taylor Wessing); Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Division
Paris CD
Richter
Technology
Pharmaceutical & Medical
Sprache
Erste Entscheidung
10. Mai 2024
Entscheidungen
  • 2024-05-10
    AbgewiesenZuständigkeitPreliminary objection

    The Paris Central Division dismissed a preliminary objection by Tandem Diabetes Care contesting the UPC's jurisdiction based on an alleged violation of a standstill agreement before filing the revocation action by Roche Diabetes Care, ruling that breach of a standstill agreement does not constitute grounds for challenging the court's jurisdiction.

    Rechtsfragen:Preliminary objection to jurisdiction (R.19 RoP)Standstill agreement and UPC jurisdictionPre-filing notice requirementsAdmissibility of revocation action
Dokumente
  • 3CDE515EC0F26C73D47167805368B7DE_en.pdf2024-05-10EN
Tandem Diabetes Care, Inc. v Roche Diabetes Care GmbH — UPC APP 3514/2024 | UPClytics